Table 2 IgA and/or IgG MT10.3:MPT64 Pleural Fluid (PF) and/or sera dilutions combination results with other antigens or ADA results that provide the best sensibility (S) and specificity (Sp) for pleural tuberculosis patients (PLTB)
MT10.3:MPT64 Combination results (sample dilutions)/ | PLTB (N = 29) N. Positive S (%) | OPL (N = 39) N. Negative Sp (%) |
|---|---|---|
Pleural Fluid IgA | ||
(1:50) / PPE59 (1:100) | 27 (93.1) | 36 (92.3) |
(1:100)/ PPE59 (1: 100) | 24 (82.7) | 37 (94.8) |
(1:200) / PPE59 (1:100); | 26 (89.6) | 37 (94.8) |
(1:50) / MPT64 (1:100); | ||
(1:50) / F2 (1:50) | ||
(1:400)/ PPE59 (1:100); | 26 (89.6) | 36 (92.3) |
(1:50) or /(1:200) or /(1:400) / MT10.3 (1:100) | ||
(1:800) / PPE59 (1:100); | 21 (72.4) | 36 (92.3) |
(1:100) / MT10.3 (1:100) | ||
(1:100) / MPT64 (1:100) | 20 (68.9) | 36 (92.3) |
(1:200) / MPT64 (1:100) or / F2 (1:50) or / MT10.3:MPT64.serum1.50 | 25 (86.2) | 36 (92.3) |
(1:400) / MPT64 (1:100) or / F2 (1:50) | 24 (82.7) | 36 (92.3) |
(1:100) / F2 (1:50) | 22 (75.8) | 36 (92.3) |
(1:50) / MT10.3-MPT64.serum1.50 | 26 (93.1) | 35 (89.7) |
(1:1000) / MT10.3-MPT64.serum1.50 | 19 (65.5) | 36 (92.3) |
Serum IgA | ||
(1.50) / MPT64 (1:50) | 13 (44.8) | 36 (92.3) |
(1.50) / MPT64 (1:200) | 14 (48.2) | 36 (92.3) |
Serum IgG | ||
(1:50) / F2 (1:400) | 15 (51.7) | 36 (92.3) |
(1:50) / F2 (1:800 or 1:1600) | 16 (55.1) | 36 (92.3) |
Pleural Fluid IgA/IgG | ||
(1:50)/ MT10.3:MPT64 (1:200) | 27 (93.1) | 36 (92.3) |
Pleural Fluid IgA | ||
(1:50) / F2 (1:50)/ ADA | 28 (96.6%) | 36 (92.3%) |